{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid3k6fhrcjkvnwpjstcduh7vfouaoig4esggfhbugudjxhukstkbe",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mjesisq4dma2"
  },
  "path": "/these-new-molecules-could-change-how-we-treat-lupus-and-arthritis/",
  "publishedAt": "2026-04-13T11:33:44.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Autoimmune Disorders",
    "Chemical Biology",
    "Immune System",
    "Pharmaceuticals",
    "Scripps Research Institute"
  ],
  "textContent": "Researchers have identified a promising new strategy to treat autoimmune diseases by targeting a specific molecular interaction within immune cells. Scripps Research scientists have created a new group of drug compounds that reduce harmful inflammation without weakening the body’s ability to fight infections, a major challenge in treating autoimmune diseases. These compounds, known as ENDOtollins, [...]",
  "title": "These New Molecules Could Change How We Treat Lupus and Arthritis"
}